Development of a Novel Virus-Like Particle-Based Vaccine Against PRV-1 Suitable for DIVA Strategies. [PDF]
Galleguillos-Becerra C +7 more
europepmc +1 more source
Immunogenicity and efficacy of an mRNA vaccine expressing a virus-like particle spike antigen against SARS-CoV-2. [PDF]
Laliberte JP +28 more
europepmc +1 more source
Porcine Parvovirus virus-like particle vaccine induces long-term humoral immunity by recruiting T follicular helper and germinal center B cell responses. [PDF]
Hao C +12 more
europepmc +1 more source
Production and characterization of monoclonal antibodies to Apple chlorotic leaf spot virus
AL RWAHNIH M +4 more
core
Capsid flexibility during Ty1 virus-like particle assembly
Sibert BS +6 more
europepmc +1 more source
Preimmunization of SPF Mice With Capsid Virus-like Particle Has no Effect on CD8<sup>+</sup> Immune Memory and Skin Inflammation in an Ovalbumin-Induced Dermatitis Model. [PDF]
Kern KS +7 more
europepmc +1 more source
Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59. [PDF]
Earnest L +27 more
europepmc +1 more source
Development and immunogenicity of adenoviral Fc-fused FMDV virus-like particle vaccine in swine. [PDF]
Park JY +9 more
europepmc +1 more source
Astragalus Polysaccharide Nanoemulsion: A Promising Adjuvant for Foot-And-Mouth Disease Virus-Like Particle Vaccines. [PDF]
Shi X +9 more
europepmc +1 more source
Preclinical Assessment of a New Virus-like Particle-Based Quadrivalent Human Papillomavirus Vaccine in Animal Models. [PDF]
Mohammadi Barzelighi H +7 more
europepmc +1 more source

